Merck & Co. Total Assets decreased by 6.0% to $128.69B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.8%, from $115.12B to $128.69B. Over 5 years (FY 2020 to FY 2025), Total Assets shows an upward trend with a 8.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Growth generally indicates business expansion, while a decline may suggest asset liquidation or a contraction in business scale.
This is the sum of all current and non-current assets owned by the company, representing the total resource base availab...
Universal financial metric used by all public companies to define the size of the balance sheet.
total_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $90.69B | $93.49B | $105.69B | $106.67B | $107.10B | $107.08B | $109.16B | $107.80B | $104.47B | $106.73B | $106.68B | $105.85B | $112.63B | $117.53B | $117.11B | $115.12B | $117.52B | $129.55B | $136.87B | $128.69B |
| QoQ Change | — | +3.1% | +13.0% | +0.9% | +0.4% | -0.0% | +1.9% | -1.2% | -3.1% | +2.2% | -0.0% | -0.8% | +6.4% | +4.4% | -0.4% | -1.7% | +2.1% | +10.2% | +5.7% | -6.0% |
| YoY Change | — | — | — | — | +18.1% | +14.5% | +3.3% | +1.1% | -2.5% | -0.3% | -2.3% | -1.8% | +7.8% | +10.1% | +9.8% | +8.8% | +4.3% | +10.2% | +16.9% | +11.8% |